| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |